MAPK8IP1P2 and thyroid gland carcinoma: Gain and loss of function assays showed that upregulating MAPK8IP1P2 inhibited, while silencing MAPK8IP1P2 enhanced anoikis resistance in vitro and lymphatic metastasis of thyroid cancer cells in vivo.